Hydrocodone Bitartrate | Excipients | Inactive | Generic | Formulation | PharmaCompass.com

Please Wait

Applying Filters...

Global API micronization market set to surge 49% by 2030, led by specialized industry pioneers

Data Compilation
#PharmaFlow

Pipeline Prospector August 2025: Novo’s Wegovy approved for MASH, Tonix Pharma’s fibromyalgia drug okayed

Stock Recap
#PipelineProspector

Hydrocodone Bitartrate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

32 API Suppliers, 17 USDMF, 1 KDMF, 16 NDC API, 9 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

41 Drugs in Development

41 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

344 FDF Dossiers, 337 FDA Orange Book, 3 Canada, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, EXTENDED RELEASE;ORAL - 10MG, CAPSULE, EXTENDED RELEASE;ORAL - 15MG, CAPSULE, EXTENDED RELEASE;ORAL - 20MG, CAPSULE, EXTENDED RELEASE;ORAL - 30MG, CAPSULE, EXTENDED RELEASE;ORAL - 40MG, CAPSULE, EXTENDED RELEASE;ORAL - 50MG, SOLUTION;ORAL - 4MG/5ML;5MG/5ML, SOLUTION;ORAL - 200MG/5ML;2.5MG/5ML, SOLUTION;ORAL - 200MG/5ML;2.5MG/5ML;30MG/5ML, SOLUTION;ORAL - 4MG/5ML;5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - 5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 1.5MG;5MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Evonik, 5 Rochem International Inc, 6 SPI Pharma, 13 DKSH, 2 Pharm-RX Chemical, 10 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 7 Kirsch Pharma, 4 ACG Worldwide, 14 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 35 BASF, 1 Bioplus Life Sciences, 3 CD Formulation, 1 Clariant, 16 Corel Pharma Chem, 7 DFE Pharma, 1 Esteem Industries, 2 Finar, 13 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures, 4 Ingredion Pharma Solutions, 26 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 5 Novo Excipients, 4 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 35 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 3 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

79 Fillers, Diluents & Binders, 58 Coating Systems & Additives, 46 Thickeners and Stabilizers, 43 Direct Compression, 40 Disintegrants & Superdisintegrants, 39 Granulation, 38 Controlled & Modified Release, 30 Solubilizers, 29 Film Formers & Plasticizers, 29 Taste Masking, 26 Parenteral, 23 Topical, 20 Lubricants & Glidants, 14 Co-Processed Excipients, 14 Chewable & Orodispersible Aids, 10 Emulsifying Agents, 10 Rheology Modifiers, 9 Empty Capsules, 8 API Stability Enhancers, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

97 News #PharmaBuzz

97 News #PharmaBuzz

GLOBAL SALES INFORMATION

30 US Medicaid Prescriptions, 6 Annual Reports

MARKET PLACE

4 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

254 US Patents

254 US Patents

REF. STANDARDS & IMPURITIES

7 Others

7 Others

$ Xls

Filters

SOLUTION;ORAL - 4MG/5ML;5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 50MG

CAPSULE, EXTENDED RELEASE;ORAL - 40MG

CAPSULE, EXTENDED RELEASE;ORAL - 30MG

CAPSULE, EXTENDED RELEASE;ORAL - 20MG

CAPSULE, EXTENDED RELEASE;ORAL - 15MG

CAPSULE, EXTENDED RELEASE;ORAL - 10MG

SOLUTION;ORAL - 4MG/5ML;5MG/5ML

SOLUTION;ORAL - 5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;ORAL - 200MG/5ML;2.5MG/5ML

SYRUP;ORAL - 1.5MG/5ML;5MG/5ML

SOLUTION;ORAL - 200MG/5ML;2.5MG/5ML;30MG/5ML

X

Contact us
to update this info